Correction: FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation

Correction: FGF1^ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation

Cell Death Dis. 2023 Apr 19;14(4):277. doi: 10.1038/s41419-023-05808-x.

Dezhong Wang^#^{1

2}, Mengyun Jin^#³, Xinyu Zhao^#¹, Tianyang Zhao¹, Wei Lin¹, Zhengle He⁴, Miaojuan Fan³, Wei Jin³, Jie Zhou¹, Lingwei Jin³, Chao Zheng^{1

3}, Hui Jin⁵, Yushuo Zhao³, Xiaokun Li^{1

2}, Lei Ying⁴, Yang Wang⁶, Guanghui Zhu^{7

8}, Zhifeng Huang⁹

¹ School of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
² School of Life and Environmental Science, Wenzhou University, Wenzhou, 325035, Zhejiang, China.
³ The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
⁴ School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
⁵ The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
⁶ School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China. [email protected].
⁷ School of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China. [email protected].
⁸ The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China. [email protected].
⁹ School of Pharmaceutical Sciences & Center for Structural Biology, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China. [email protected].

^# Contributed equally.

No abstract available